Clearance Summary
BostonSight IC Corneal Lens, BostonSight IC Scleral Lens received FDA 510(k) clearance under submission number K153066, sponsored by Boston Foundation For Sight. The device was reviewed via the Traditional premarket notification pathway and assigned to the Ophthalmic review panel. The statutory decision date of record is 2016-02-09.
- Submission: K153066
- Applicant / Sponsor: Boston Foundation For Sight
- Clearance pathway: Traditional
- Review panel: Ophthalmic
- Device class: Class II
- Regulation citation: 21 CFR 886.5916
- Decision date: 2016-02-09
Classification & Regulation
This clearance is catalogued under FDA product code HQD and 21 CFR 886.5916, within the Ophthalmic review panel as a Class II device.